Buy Tirzepatide Ultima Pharmaceuticals 5 mg/vial – USA Domestic, High-Purity Injectable
Introduction
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that enhances glycemic control and promotes weight loss. It is FDA-approved under brand names such as Mounjaro and Zepbound for type 2 diabetes and obesity treatment. Research dosing typically starts at 2.5 mg subcutaneously once weekly, increasing to 5 mg after four weeks, with further titration possible up to 15 mg depending on study protocols and tolerability.
Ultima Pharmaceuticals’ Tirzepatide 5 mg vial provides a reliable source of this potent peptide for research applications, supporting investigations into metabolic regulation, appetite control, and cardiovascular benefits.
Key Features & Benefits
-
Contains 5 mg of high-purity Tirzepatide per vial in lyophilized powder form.
-
Dual GIP/GLP-1 receptor agonist promoting improved glycemic control and weight loss.
-
Suitable for subcutaneous injection after reconstitution.
-
Manufactured under strict pharmaceutical quality standards.
-
Shipped domestically within the USA with discreet, vacuum-sealed packaging.
-
Supports research in diabetes, obesity, metabolic syndrome, and related fields.
Product Specifications
| Specification | Details |
|---|---|
| Active Ingredient | Tirzepatide |
| Dosage Strength | 5 mg per vial |
| Form | Lyophilized powder for injection |
| Administration | Subcutaneous injection |
| Storage Conditions | Store refrigerated before reconstitution; use reconstituted solution as recommended |
| Shipping | USA domestic, discreet packaging |
Applications & Usage
Tirzepatide 5 mg is used in research to:
-
Study mechanisms of dual GIP and GLP-1 receptor activation on glucose metabolism.
-
Investigate effects on insulin secretion, appetite regulation, and weight loss.
-
Explore therapeutic potential in type 2 diabetes, obesity, and metabolic disorders.
-
Support pharmacokinetic, pharmacodynamic, and safety profiling studies.
Typical dosing begins at 2.5 mg weekly, increasing to 5 mg after four weeks, with further titration based on research goals and tolerability.
Purity & Testing
Each batch undergoes rigorous quality control testing:
-
High-Performance Liquid Chromatography (HPLC) to confirm purity and potency.
-
Sterility and endotoxin testing for safety.
-
Certificate of Analysis (COA) provided for quality assurance and transparency.
Safety & Handling Guidelines
Tirzepatide is intended strictly for laboratory and clinical research use only. It is not for unauthorized human or animal consumption. Handle with appropriate personal protective equipment (PPE). Follow proper reconstitution and injection protocols. Store vials refrigerated before use and handle reconstituted solutions as recommended.
Global Shipping & Discreet Delivery
-
Shipped domestically within the USA with secure, plain packaging.
-
Vacuum-sealed vials protect product integrity during transit.
-
Fast, trackable delivery with confidentiality ensured.
Why Choose Us?
-
Authorized supplier of Ultima Pharmaceuticals products.
-
Prompt order processing with expedited domestic shipping.
-
Stealth packaging for privacy and product safety.
-
Expert customer support for ordering and technical inquiries.
Legal & Safety Disclaimer
This product is sold exclusively for research purposes and is not intended for unauthorized human or animal consumption. Buyers must be 18 years or older and comply with all applicable laws and regulations. Liability for misuse or illegal activities is disclaimed.
FAQ
What is the typical starting dose of Tirzepatide in research?
The initial dose is usually 2.5 mg subcutaneously once weekly, increasing to 5 mg after four weeks.
Can the dose be increased beyond 5 mg?
Yes, doses can be increased in 2.5 mg increments every 4 weeks up to a maximum of 15 mg weekly, depending on research protocols.
How is Tirzepatide administered?
By subcutaneous injection after reconstitution of the lyophilized powder.
How discreet is the shipping?
All orders ship in plain, unmarked packaging with vacuum sealing to ensure maximum confidentiality.
How should Tirzepatide vials be stored?
Store refrigerated before reconstitution; use reconstituted solution as per manufacturer guidelines.
Purchase Tirzepatide 5 mg vial by Ultima Pharmaceuticals for research with fast, discreet USA domestic shipping. High-quality GIP/GLP-1 receptor agonist for metabolic and weight loss studies.
